Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma
Early Phase 1
Completed
- Conditions
- Pyoderma GangrenosumPyoderma VegetansPyodermaPyoderma Gangrenosum Surrounding Surgical Stoma
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- SWISS BIOPHARMA MED GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT04895566
- Locations
- 🇱🇻
Contract Research Organization, Rīga, Latvia
News
No news found